Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Navidea Biopharmaceuticals, Inc. (NAVBQ)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address
4995 Bradenton Avenue 43017-3552
Dublin, OH, US
Dublin, OH, US
CEO
Craig A. Dais
Website
navidea.com
IPO
2025-09-29
CIK 810509 ISIN US63937X2027
Also trades on
Other OTC · NAVB (USD)
Other OTC · NAVBQ (USD)
Description
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical firm dedicated to advancing and commercializing specialized agents for immunodiagnosis and innovative immunotherapeutics. The company operates across two distinct segments: Diagnostic Substances and Therapeutic Development Programs. Its core technology, the Manocept platform, is designed to target the CD206 mannose receptor, which is prominently found on activated macrophages. This platform enables a variety of diagnostic imaging techniques, including single photon emission computed tomography (SPECT), positron emission tomography (PET), gamma-scanning, and both intra-operative and optical-fluorescence detection methods. Beyond diagnostics, Manocept also facilitates the targeted delivery of therapeutic compounds to macrophages, addressing diseases characterized by immune system involvement and inflammation. Among its key pipeline assets, NAV3-31 has successfully completed Phase IIb clinical trials. These trials assessed the imaging repeatability, reproducibility, and stability, along with the effectiveness of Tc99m tilmanocept imaging in monitoring anti-tumor necrosis factor alpha therapy for patients with moderate to severe rheumatoid arthritis (RA). NAV3-35 is currently undergoing a Phase IIb clinical trial for RA imaging, while NAV3-33 is advancing through Phase III clinical trials, also for RA. Furthermore, NAV3-32 is participating in a Phase 2b trial specifically for RA-involved joints. The company is also exploring the utility of Tc99m tilmanocept in other therapeutic areas, such as cardiovascular conditions, Kaposi's sarcoma, tuberculosis, and various other immunotherapeutic applications. Originally established as Neoprobe Corporation, the company officially adopted the name Navidea Biopharmaceuticals, Inc. in January 2012. Founded in 1983, its corporate headquarters are situated in Dublin, Ohio. In a significant corporate development, Navidea Biopharmaceuticals, Inc. initiated voluntary reorganization proceedings under Chapter 11 with the U.S. Bankruptcy Court for the District of Delaware on October 1, 2025.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
12.0K
Beta
-4.82
Float Shares
68.23M
Free Float %
68.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +9,900.00% | -80.00% | +9,900.00% | -85.71% | -99.88% | -99.99% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (8 ratings, all time)
Buy
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-100.75
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-87.7% Q3'23: -100.0% (vs Q3'22)
-
EPS growth Biotechnology: +29.7%-40.0% Q3'23: +90.9% (vs Q3'22)
-
FCF margin FCF growth · Biotechnology: +16.2%-15,322.0%
-
EBIT margin Biotechnology: +0.0%-21,444.6%
-
ROIC Biotechnology: -16.1%— Q3'23: +152.6% (vs Q3'22)
-
Share dilution Biotechnology: -3.4%+5.3% Q3'23: +223.3% (vs Q3'22)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.17× Q3'23: -0.15× (vs Q3'22)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|
| Revenue |
44.55M
est.
|
112.47M
est.
|
| EBITDA |
-44.55M
est.
|
-112.47M
est.
|
| EBIT |
-44.55M
est.
|
-112.47M
est.
|
| Net Income |
17.61M
est.
|
72.93M
est.
|
| SGA |
3.58B
est.
|
9.05B
est.
|
| EPS |
0.57
est.
|
2.36
est.
|
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-9.94M
OE per share TTM
-0.14
Owner's Yield
-100,071.87%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
31.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.00
Bullish
Ratio by volume
3.00
Bullish
Buys
4
Sells
2
Shares acquired
23.97M
Shares disposed
13.0K
Cash buys
1.00
Cash sales
—
Net activity
+23,957,682
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-27 | Scott John K Jr. | Director / 10% Owner | J-Other | A | Series J Convertible Preffered Stock | 64,289 | 0.10 | 6.7K | 64,289 | — | ↗ |
| 2023-11-16 | Stefanelli Jill | Director | A-Award | A | Common Stock | 416,667 | 0.00 | — | 941,667 | — | ↗ |
| 2023-11-16 | Moss Dana J | Director | A-Award | A | Common Stock | 416,667 | 0.00 | — | 866,667 | — | ↗ |
| 2023-07-28 | Dais Craig | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-11 | Moss Dana J | Director | A-Award | A | Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-06-29 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 12,200,000 | 0.09 | 1.07M | 31,755,832 | — | ↗ |
| 2023-06-08 | Stefanelli Jill | Director | A-Award | A | Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-06-05 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 11,508,672 | 0.00 | 11.5K | 19,555,832 | — | ↗ |
| 2023-06-01 | Stefanelli Jill | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | Scott John K Jr. | Director / 10% Owner | P-Purchase | A | Series J Convertible Preferred Stock | 11,969 | 0.10 | 1.2K | 11,969 | — | ↗ |
| 2022-11-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 163,888 | — | ↗ |
| 2022-11-30 | Scott John K Jr. | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 8,109,645 | — | ↗ |
| 2022-11-30 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 67,727 | — | ↗ |
| 2022-11-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 71,818 | — | ↗ |
| 2022-11-29 | Wilson Joshua M. | Director | A-Award | A | Common Stock | 30,000 | 0.00 | 30.00 | 30,000 | — | ↗ |
| 2022-10-31 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 163,888 | — | ↗ |
| 2022-10-31 | Scott John K Jr. | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,108,395 | — | ↗ |
| 2022-10-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 66,477 | — | ↗ |
| 2022-10-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 70,568 | — | ↗ |
| 2022-09-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 161,388 | — | ↗ |
| 2022-09-30 | Wilson Joshua M. | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-09-30 | Scott John K Jr. | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,105,895 | — | ↗ |
| 2022-09-30 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 63,977 | — | ↗ |
| 2022-09-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 68,068 | — | ↗ |
| 2022-08-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 61,477 | — | ↗ |
| 2022-08-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 65,568 | — | ↗ |
| 2022-08-30 | Witter Malcolm G | Director | P-Purchase | A | Series I Convertible Preferred Stock | 115 | 0.45 | 51.75 | 115 | — | ↗ |
| 2022-08-30 | Scott John K Jr. | Director | P-Purchase | A | Series I Convertible Preferred Stock | 2,400 | 0.00 | — | 2,400 | — | ↗ |
| 2022-07-31 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 156,388 | — | ↗ |
| 2022-07-31 | Scott John K Jr. | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,100,895 | — | ↗ |
| 2022-07-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 58,977 | — | ↗ |
| 2022-07-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 63,068 | — | ↗ |
| 2022-06-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 153,888 | — | ↗ |
| 2022-06-30 | Scott John K Jr. | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,098,395 | — | ↗ |
| 2022-06-30 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 56,477 | — | ↗ |
| 2022-06-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 60,568 | — | ↗ |
| 2022-05-31 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 151,388 | — | ↗ |
| 2022-05-31 | Scott John K Jr. | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,095,895 | — | ↗ |
| 2022-05-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 53,977 | — | ↗ |
| 2022-05-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 58,068 | — | ↗ |
| 2022-04-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 148,888 | — | ↗ |
| 2022-04-30 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 51,477 | — | ↗ |
| 2022-04-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 55,568 | — | ↗ |
| 2022-04-10 | Scott John K Jr. | Director | P-Purchase | A | Series G Redeemable Preferred Stock | 3,260 | 0.00 | — | 3,260 | — | ↗ |
| 2022-03-31 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 146,388 | — | ↗ |
| 2022-03-31 | Scott John K Jr. | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,090,895 | — | ↗ |
| 2022-03-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 48,977 | — | ↗ |
| 2022-03-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 53,068 | — | ↗ |
| 2022-02-28 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 143,888 | — | ↗ |
| 2022-02-28 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,088,395 | — | ↗ |
| 2022-02-28 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 46,477 | — | ↗ |
| 2022-02-28 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 50,568 | — | ↗ |
| 2022-01-31 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 141,388 | — | ↗ |
| 2022-01-31 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,085,895 | — | ↗ |
| 2022-01-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 43,977 | — | ↗ |
| 2022-01-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 48,068 | — | ↗ |
| 2022-01-14 | Rosol Michael Stanley | Officer | A-Award | A | Common Stock | 7,728 | 0.00 | — | 14,575 | — | ↗ |
| 2021-12-31 | Witter Malcolm G | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 138,888 | — | ↗ |
| 2021-12-31 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 2,500 | 0.00 | — | 8,083,395 | — | ↗ |
| 2021-12-31 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 41,477 | — | ↗ |
| 2021-12-31 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 45,568 | — | ↗ |
| 2021-12-27 | Rosol Michael Stanley | Officer | A-Award | A | Stock Option | 100,000 | 1.08 | 108.0K | 100,000 | — | ↗ |
| 2021-11-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 136,388 | — | ↗ |
| 2021-11-30 | Winkler Agnieszka | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 33,600 | — | ↗ |
| 2021-11-30 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 1,250 | 0.00 | — | 8,080,895 | — | ↗ |
| 2021-11-30 | FARB THOMAS F | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 33,425 | — | ↗ |
| 2021-11-30 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 38,977 | — | ↗ |
| 2021-11-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 1,250 | 0.00 | — | 43,068 | — | ↗ |
| 2021-11-15 | Witter Malcolm G | Director | A-Award | A | Common Stock | 30,000 | 0.00 | 30.00 | 132,252 | — | ↗ |
| 2021-11-15 | Winkler Agnieszka | Director | A-Award | A | Common Stock | 30,000 | 0.00 | 30.00 | 30,000 | — | ↗ |
| 2021-11-15 | Scott John K Jr. | Director / 10% Owner | A-Award | A | Common Stock | 30,000 | 0.00 | 30.00 | 8,077,162 | — | ↗ |
| 2021-11-15 | Mikhail Michel | Officer | A-Award | A | Stock Option | 75,000 | 1.37 | 102.8K | 75,000 | — | ↗ |
| 2021-11-15 | FARB THOMAS F | Director | A-Award | A | Common Stock | 30,000 | 0.00 | 30.00 | 30,000 | — | ↗ |
| 2021-11-15 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 3,965 | 0.00 | — | 37,727 | — | ↗ |
| 2021-11-15 | Bhalla Amit | Director | A-Award | A | Common Stock | 30,000 | 0.00 | 30.00 | 39,195 | — | ↗ |
| 2021-10-07 | Winkler Agnieszka | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-07 | FARB THOMAS F | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-01 | Mikhail Michel | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 3,995 | 0.00 | — | 102,252 | — | ↗ |
| 2021-09-30 | CAPPELLO ALEXANDER L | Director | A-Award | A | Common Stock | 3,762 | 0.00 | — | 3,762 | — | ↗ |
| 2021-09-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 4,286 | 0.00 | — | 9,195 | — | ↗ |
| 2021-09-17 | Witter Malcolm G | Director | P-Purchase | A | Common Stock | 20,000 | 1.60 | 32.0K | 98,257 | — | ↗ |
| 2021-07-26 | Witter Malcolm G | Director | P-Purchase | A | Common Stock | 15,000 | 1.70 | 25.5K | 78,257 | — | ↗ |
| 2021-07-09 | CAPPELLO ALEXANDER L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | Witter Malcolm G | Director | A-Award | A | Common Stock | 3,757 | 0.00 | — | 63,257 | — | ↗ |
| 2021-06-30 | Rouan Sarah Kathryn | Director | A-Award | A | Common Stock | 4,892 | 0.00 | — | 18,242 | — | ↗ |
| 2021-06-30 | Bruck Claudine | Director | A-Award | A | Common Stock | 3,969 | 0.00 | — | 16,519 | — | ↗ |
| 2021-06-30 | Bhalla Amit | Director | A-Award | A | Common Stock | 2,409 | 0.00 | — | 4,909 | — | ↗ |
| 2021-05-04 | Bhalla Amit | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-23 | Witter Malcolm G | Director | P-Purchase | A | Common Stock | 10,000 | 1.60 | 16.0K | 57,000 | — | ↗ |
| 2021-03-29 | Witter Malcolm G | Director | P-Purchase | A | Common Stock | 21,500 | 2.07 | 44.5K | 47,000 | — | ↗ |
| 2021-03-03 | Witter Malcolm G | Director | P-Purchase | A | Common Stock | 15,000 | 2.31 | 34.7K | 25,500 | — | ↗ |
| 2021-03-02 | Scott John K Jr. | 10% Owner | P-Purchase | A | Series E Redeemable Convertible Preferred Stock | 50,000 | 2.30 | 115.0K | 50,000 | — | ↗ |
| 2021-02-15 | Rosol Michael Stanley | Officer | A-Award | A | Stock Option | 25,000 | 2.56 | 64.0K | 25,000 | — | ↗ |
| 2021-02-15 | Latkin Jed | Director / Officer | A-Award | A | Stock Option | 100,000 | 2.56 | 256.0K | 100,000 | — | ↗ |
| 2021-02-15 | Kaufman Joel H. | Officer | A-Award | A | Stock Option | 25,000 | 2.56 | 64.0K | 25,000 | — | ↗ |
| 2021-01-13 | Witter Malcolm G | Director | A-Award | A | Stock Option | 2,500 | 2.28 | 5.7K | 2,500 | — | ↗ |
| 2021-01-13 | Rouan Sarah Kathryn | Director | A-Award | A | Stock Option | 2,500 | 2.28 | 5.7K | 2,500 | — | ↗ |
| 2021-01-13 | RICE YEHUDA MICHAEL | Director | A-Award | A | Common Stock | 2,500 | 0.00 | 2.50 | 12,500 | — | ↗ |
| 2021-01-13 | Cutler Adam D. | Director | A-Award | A | Stock Option | 2,500 | 2.28 | 5.7K | 2,500 | — | ↗ |
| 2021-01-13 | Bruck Claudine | Director | A-Award | A | Common Stock | 2,500 | 0.00 | 2.50 | 12,550 | — | ↗ |
| 2020-12-28 | Witter Malcolm G | Director | P-Purchase | A | Common Stock | 5,000 | 2.07 | 10.4K | 10,500 | — | ↗ |
| 2020-11-04 | Kaufman Joel H. | Officer | — | D | Stock Option | 6,000 | 1.06 | 6.4K | 0 | — | ↗ |
| 2020-08-30 | Scott John K Jr. | 10% Owner | P-Purchase | A | Common Stock | 5,000 | 5.00 | 25.0K | 8,047,162 | — | ↗ |
| 2020-08-14 | Latkin Jed | Director / Officer | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 107,997 | — | ↗ |
| 2020-06-02 | Rosol Michael Stanley | Officer | A-Award | A | Common Stock | 6,847 | 2.62 | 17.9K | 13,097 | — | ↗ |
| 2020-06-02 | Latkin Jed | Director / Officer | A-Award | A | Common Stock | 33,997 | 2.62 | 89.1K | 57,997 | — | ↗ |
| 2020-02-20 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 1.08 | 5.4K | 17,950 | — | ↗ |
| 2020-02-13 | Scott John K Jr. | 10% Owner | P-Purchase | A | Common Stock | 2,373,529 | 0.85 | 2.02M | 8,042,162 | — | ↗ |
| 2020-02-06 | Rouan Sarah Kathryn | Director | A-Award | A | Stock Option | 2,500 | 1.06 | 2.7K | 7,500 | — | ↗ |
| 2020-02-06 | Rosol Michael Stanley | Officer | A-Award | A | Stock Option | 25,000 | 1.06 | 26.5K | 31,250 | — | ↗ |
| 2020-02-06 | RICE YEHUDA MICHAEL | Director | A-Award | A | Common Stock | 2,500 | 0.00 | 2.50 | 10,000 | — | ↗ |
| 2020-02-06 | Latkin Jed | Director / Officer | A-Award | A | Stock Option | 100,000 | 1.06 | 106.0K | 203,250 | — | ↗ |
| 2020-02-06 | Cutler Adam D. | Director | A-Award | A | Stock Option | 2,500 | 1.06 | 2.7K | 7,500 | — | ↗ |
| 2020-02-06 | Bruck Claudine | Director | A-Award | A | Common Stock | 2,500 | 0.00 | 2.50 | 10,050 | — | ↗ |
| 2019-12-06 | Scott John K Jr. | 10% Owner | P-Purchase | A | Common Stock | 555,555 | 0.90 | 500.0K | 5,668,633 | — | ↗ |
| 2019-06-18 | Scott John K Jr. | 10% Owner | P-Purchase | A | Common Stock | 4,000,000 | 0.75 | 3.00M | 5,113,078 | — | ↗ |
| 2019-06-05 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.26 | 1.3K | 12,950 | — | ↗ |
| 2019-05-17 | Rouan Sarah Kathryn | Director | P-Purchase | A | Common Stock | 3,350 | 1.46 | 4.9K | 8,350 | — | ↗ |
| 2019-05-17 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.46 | 1.5K | 11,950 | — | ↗ |
| 2019-05-16 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 1.45 | 2.2K | 10,950 | — | ↗ |
| 2019-05-15 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.45 | 1.4K | 9,450 | — | ↗ |
| 2019-05-14 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 1.84 | 3.7K | 8,450 | — | ↗ |
| 2019-05-13 | Latkin Jed | Director / Officer | P-Purchase | A | Common Stock | 2,400 | 1.91 | 4.6K | 6,450 | — | ↗ |
| 2019-05-13 | Bruck Claudine | Director | P-Purchase | A | Common Stock | 2,550 | 1.90 | 4.9K | 7,550 | — | ↗ |
| 2019-03-22 | Scott John K Jr. | 10% Owner | P-Purchase | A | Common Stock | 357,143 | 0.14 | 50.0K | 22,261,565 | — | ↗ |
| 2019-02-07 | Rouan Sarah Kathryn | Director | A-Award | A | Stock Option | 50,000 | 0.25 | 12.5K | 100,000 | — | ↗ |
| 2019-02-07 | RICE YEHUDA MICHAEL | Director | A-Award | A | Stock Option | 50,000 | 0.25 | 12.5K | 150,000 | — | ↗ |
| 2019-02-07 | Latkin Jed | Director / Officer | A-Award | A | Stock Option | 1,000,000 | 0.00 | — | 2,065,000 | — | ↗ |
| 2019-02-07 | Cutler Adam D. | Director | A-Award | A | Stock Option | 50,000 | 0.25 | 12.5K | 100,000 | — | ↗ |
| 2019-02-07 | Bruck Claudine | Director | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 100,000 | — | ↗ |
| 2019-01-02 | Rouan Sarah Kathryn | Director | A-Award | A | Stock Option | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2019-01-02 | Rosol Michael Stanley | Officer | A-Award | A | Stock Option | 125,000 | 0.38 | 47.5K | 125,000 | — | ↗ |
| 2019-01-02 | Cutler Adam D. | Director | A-Award | A | Stock Option | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2018-12-17 | Rosol Michael Stanley | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-12-01 | Rouan Sarah Kathryn | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-12-01 | Cutler Adam D. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-09-13 | Scott John K Jr. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 21,904,422 | — | ↗ |
| 2018-06-29 | Cope Frederick O | Officer | A-Award | A | Common Stock | 212,390 | 0.23 | 48.8K | 585,052 | — | ↗ |
| 2018-03-15 | Bruck Claudine | Director | A-Award | A | Stock Option | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2018-03-05 | Bruck Claudine | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-02-20 | Rowinsky Eric K | Director | A-Award | A | Stock Option | 50,000 | 0.75 | 37.5K | 173,764 | — | ↗ |
| 2018-02-20 | RICE YEHUDA MICHAEL | Director | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 100,000 | — | ↗ |
| 2018-02-20 | Greene Mark I | Director | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 157,244 | — | ↗ |
| 2018-02-20 | Cope Frederick O | Officer | A-Award | A | Common Stock | 135,694 | 0.36 | 48.8K | 372,662 | — | ↗ |
| 2017-10-13 | Gonzalez Ricardo J | Officer | — | D | Inducement Stock Option | 400,000 | 1.26 | 504.0K | 0 | — | ↗ |
| 2017-09-14 | RICE YEHUDA MICHAEL | Director | G-Gift | D | Common Stock | 28,000 | 0.00 | — | 50,000 | — | ↗ |
| 2017-06-30 | Rowinsky Eric K | Director | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 291,446 | — | ↗ |
| 2017-06-30 | RICE YEHUDA MICHAEL | Director | A-Award | A | Stock Option | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2017-06-30 | Greene Mark I | Director | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 107,244 | — | ↗ |
| 2017-06-30 | Fiorino Anthony S. | Director | A-Award | A | Common Stock | 50,000 | 0.00 | 50.00 | 78,000 | — | ↗ |
| 2017-06-29 | Regan William J. | Officer | P-Purchase | A | Common Stock | 20,000 | 0.53 | 10.6K | 172,977 | — | ↗ |
| 2017-05-30 | Latkin Jed | — | P-Purchase | A | Common Stock, $.001 par value | 7,600 | 0.44 | 3.3K | 50,159 | — | ↗ |
| 2017-05-22 | Latkin Jed | — | P-Purchase | A | Common Stock, $.001 par value | 11,200 | 0.45 | 5.0K | 42,559 | — | ↗ |
| 2017-05-19 | Latkin Jed | — | P-Purchase | A | Common Stock, $.001 par value | 14,159 | 0.45 | 6.4K | 31,359 | — | ↗ |
| 2017-05-18 | Latkin Jed | — | A-Award | A | Common Stock, $.001 par value | 3,900 | 0.45 | 1.8K | 17,200 | — | ↗ |
| 2017-05-17 | Latkin Jed | — | A-Award | A | Common Stock, $.001 par value | 13,300 | 0.47 | 6.2K | 13,300 | — | ↗ |
| 2017-05-16 | GOLDBERG MICHAEL M | — | A-Award | A | Common Stock, $.001 par value | 106,021 | 0.46 | 48.8K | 5,921,023 | — | ↗ |
| 2017-05-04 | Latkin Jed | — | A-Award | A | Stock Option (Right to Buy) | 1,000,000 | 0.00 | — | 1,065,000 | — | ↗ |
| 2017-02-06 | Regan William J. | Officer | A-Award | A | NAVB Common Stock, $.001 par value | 79,155 | 0.52 | 41.2K | 116,962 | — | ↗ |
| 2017-02-06 | Klima Thomas J | Officer | A-Award | A | NAVB Common Stock, $.001 par value | 50,885 | 0.52 | 26.5K | 51,935 | — | ↗ |
| 2017-02-06 | Cope Frederick O | Officer | A-Award | A | NAVB Common Stock, $.001 par value | 88,378 | 0.52 | 46.0K | 180,593 | — | ↗ |
| 2017-01-17 | GOLDBERG MICHAEL M | Director / Officer | X-InTheMoney | A | NAVB Common Stock, $.001 par value | 5,411,850 | 0.01 | 54.1K | 5,815,002 | — | ↗ |
| 2017-01-10 | Greene Mark I | Director | A-Award | A | Common Stock | 16,406 | 0.64 | 10.5K | 57,244 | — | ↗ |
| 2016-10-17 | Greene Mark I | Director | A-Award | A | Common Stock | 11,413 | 0.87 | 9.9K | 40,838 | — | ↗ |
| 2016-10-17 | GOLDBERG MICHAEL M | Director / Officer | J-Other | A | Warrants (Right to Buy) | 5,411,850 | 0.01 | 54.1K | 5,411,850 | — | ↗ |
| 2016-10-14 | Latkin Jed | Officer | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.00 | 20.0K | 20,000 | — | ↗ |
| 2016-07-06 | GOLDBERG MICHAEL M | Director | A-Award | A | Common Stock | 43,580 | 0.50 | 21.8K | 403,152 | — | ↗ |
| 2016-06-14 | RICE YEHUDA MICHAEL | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 28,000 | — | ↗ |
| 2016-05-04 | RICE YEHUDA MICHAEL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-04-27 | Greene Mark I | Director | A-Award | A | Common Stock | 1,425 | 1.37 | 2.0K | 29,425 | — | ↗ |
| 2016-04-20 | Troup Gordon A | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 265,568 | — | ↗ |
| 2016-04-20 | Rowinsky Eric K | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 224,446 | — | ↗ |
| 2016-04-20 | Latkin Jed | Officer | — | D | Stock Option (Right to Buy) | 45,000 | 1.50 | 67.5K | 0 | — | ↗ |
| 2016-04-20 | Greene Mark I | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 28,000 | — | ↗ |
| 2016-04-20 | GOLDBERG MICHAEL M | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 359,572 | — | ↗ |
| 2016-04-20 | Fiorino Anthony S. | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 28,000 | — | ↗ |
| 2016-04-08 | Rowinsky Eric K | Director | A-Award | A | Common Stock | 10,726 | 1.14 | 12.2K | 196,446 | — | ↗ |
| 2016-03-23 | Greene Mark I | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-03-23 | Fiorino Anthony S. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-02-25 | Regan William J. | Officer | A-Award | A | Stock Option (Right to Buy) | 52,405 | 0.98 | 51.4K | 52,405 | — | ↗ |
| 2016-02-25 | LARSON BRENT L | Officer | A-Award | A | Stock Option (Right to Buy) | 54,501 | 0.98 | 53.4K | 54,501 | — | ↗ |
| 2016-02-25 | Klima Thomas J | Officer | A-Award | A | Stock Option (Right to Buy) | 56,598 | 0.98 | 55.5K | 56,598 | — | ↗ |
| 2016-02-25 | Cope Frederick O | Officer | A-Award | A | Common Stock (Right to Buy) | 58,510 | 0.98 | 57.3K | 58,510 | — | ↗ |
| 2016-01-06 | GUETH ANTON | Director | A-Award | A | Common Stock | 16,918 | 1.22 | 20.6K | 38,918 | — | ↗ |
| 2015-12-01 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 1.50 | 18.8K | 222,237 | — | ↗ |
| 2015-11-02 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 1.98 | 24.8K | 234,737 | — | ↗ |
| 2015-10-09 | Troup Gordon A | Director | A-Award | A | Common Stock | 5,254 | 2.24 | 11.8K | 237,568 | — | ↗ |
| 2015-10-08 | GOLDBERG MICHAEL M | Director | A-Award | A | Common Stock | 13,247 | 2.26 | 29.9K | 331,572 | — | ↗ |
| 2015-10-01 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 2.27 | 28.4K | 247,237 | — | ↗ |
| 2015-09-01 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 1.88 | 23.5K | 259,737 | — | ↗ |
| 2015-08-03 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 1.71 | 21.3K | 272,237 | — | ↗ |
| 2015-07-31 | FORD BRENDAN A | Director | A-Award | A | Common Stock | 9,317 | 1.61 | 15.0K | 239,950 | — | ↗ |
| 2015-07-26 | Troup Gordon A | Director | A-Award | A | Common Stock | 10,559 | 1.61 | 17.0K | 232,314 | — | ↗ |
| 2015-07-16 | KARSEN PERRY A | Director | D-Return | D | Common Stock | 22,000 | 0.01 | 220.00 | 37,528 | — | ↗ |
| 2015-07-16 | DRAKE PETER F | Director | D-Return | D | Common Stock | 22,000 | 0.01 | 220.00 | 77,829 | — | ↗ |
| 2015-07-02 | Tomblyn Michael | Officer | — | D | Common Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2015-07-02 | GUETH ANTON | Director | A-Award | A | Common Stock | 22,000 | 0.00 | 22.00 | 22,000 | — | ↗ |
| 2015-07-01 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 1.61 | 20.1K | 284,737 | — | ↗ |
| 2015-06-01 | LARSON BRENT L | Officer | S-Sale | D | Common Stock | 12,500 | 1.24 | 15.5K | 297,237 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-12.8K
Shares Outstanding
100.08M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2009 | David C. Bupp President and Chief Executive Officer | 335.0K | 45.0K | 565.3K | — | — | 8.6K | 953.9K | 59.26% | ↗ |
| 2 | 2009 | Frederick O. Cope, Ph.D. Vice President, Pharmaceutical Research and Clinical Development | 175.0K | 25.0K | 147.3K | 78.5K | — | 4.4K | 430.2K | 52.50% | ↗ |
| 3 | 2009 | Brent L. Larson Vice President, Finance and Chief Financial Officer | 184.0K | 15.3K | 82.4K | 65.2K | — | 4.9K | 351.9K | 41.96% | ↗ |
| 4 | 2008 | David C. Bupp President and Chief Executive Officer | 325.0K | 40.0K | 107.7K | 58.0K | — | 9.4K | 540.1K | 30.67% | ↗ |
| 5 | 2008 | Brent L. Larson Vice President, Finance and Chief Financial Officer | 177.0K | 15.0K | 18.0K | 14.5K | — | 5.4K | 229.9K | 14.11% | ↗ |
| 6 | 2008 | Anthony K. Blair Vice President, Manufacturing Operations | 150.0K | 15.7K | 9.0K | 10.8K | — | 4.7K | 190.2K | 10.41% | ↗ |
| 7 | 2007 | David C. Bupp President and Chief Executive Officer | 305.0K | 60.0K | — | 51.8K | — | 8.4K | 425.0K | 12.19% | ↗ |
| 8 | 2007 | Brent L. Larson Vice President, Finance and Chief Financial Officer | 170.0K | 19.1K | — | 10.2K | — | 4.9K | 204.2K | 4.99% | ↗ |
| 9 | 2007 | Anthony K. Blair Vice President, Manufacturing Operations | 134.0K | 19.1K | — | 8.6K | — | 3.9K | 165.6K | 5.16% | ↗ |
| 10 | 2006 | David C. Bupp President and Chief Executive Officer | 305.0K | 20.0K | — | 60.0K | — | 8.1K | 393.1K | 15.26% | ↗ |
| 11 | 2006 | Brent L. Larson Vice President, Finance and Chief Financial Officer | 160.0K | 5.0K | — | 16.2K | — | 4.6K | 185.8K | 8.71% | ↗ |
| 12 | 2006 | Anthony K. Blair Vice President, Manufacturing Operations | 122.0K | 4.6K | — | 12.3K | — | 3.4K | 142.3K | 8.66% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Craig A. Dais | Chief Financial Officer & Principal Accounting Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NAVBQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
